Research Paper Volume 13, Issue 3 pp 3501—3517
A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling
Figure 1. Foxp3 expression in high-grade gliomas from SYSUCC and survival analysis. (A) Foxp3 expression in 72 high-grade gliomas from SYSUCC, black arrows shows the positive cells. The scale bar represents 50 μm. (B) Comparison of survival prognosis between 34 Foxp3-positive patients and 38 Foxp3-negative patients from SYSUCC (Log-Rank test).